U.S. Food And Drug Administration

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

Topic Paragraphs

Featured

Holidays Are A Time To Share

Just don’t share “food poisoning” with your friends and family.

Highly Pathogenic Avian Influenza (HPAI)

FDA’s Response to Ensure Continued Effectiveness of Federal-State Milk Safety System

Know When and How to Use Antibiotics, and When to Skip Them

Antibiotics are powerful medications that save countless lives every day. But they’re not the answer for every illness.

FDA Modernization Efforts for Establishing a Unified Human Foods Program

The unified Human Foods Program, a new model and name for field operations and other modernization efforts are now in effect.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Report a Problem with an FDA Regulated Product

Nov 26

FDA Roundup: November 26, 2024

Nov 22

FDA Roundup: November 22, 2024

More Press Announcements Newsroom Meetings Testimony Speeches

Nov 28

Gracie’s Kitchen’s Inc. Recalls Read-To-Eat Products Manufactured Between 11/4 and 11/13/24 Because of Possible Health Risk

Food & Beverages

Nov 27

Handsome Brook Farms Issues Recall of Kirkland Signature Organic Pasture Raised 24-Count Eggs Because of Possible Health Risk

Food & Beverages

Nov 27

Sunfed Produce, LLC Recalls Whole Fresh American Cucumbers Because of Possible Health Risks Due to Salmonella

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List Paragraph Header

Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice

OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.

One Health - Optimal Public Health Outcomes for Humans and Animals in Our Shared Environment

FDA collaborates with stakeholders across disciplines and sectors to promote the health of humans, animals, and the environment.

FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub

The Hub will act as the single point of engagement and connection with outside parties for drug and biological product development.

View More...

Nov 27

Recommended Followup Testing for an Ames-Positive Drug (Active Ingredient) or Metabolite To Support First-in-Human Clinical Trials With Healthy Subjects

Drugs

Nov 27

Use of Circulating Tumor Deoxyribonucleic Acid for Early-Stage Solid Tumor Drug Development; Guidance for Industry; Availability

Nov 26

Assessment of Ovarian Toxicity in Premenopausal Adults During Drug Development for Oncologic Products

Biologics, Drugs

FDA Guidance Search

Jobs at FDA

Inspections and Compliance

MedWatch: Safety Alerts

Science & Research

FDA Organization

Import Program

Warning Letters

Combination Products

Rumor Control

Criminal Investigations

Disposal of Unused Medicines

Emergency Preparedness

Back to Top